Tectonic Therapeutic, Inc. (NasdaqGM: TECX)
Health Care · Biotechnology · US
$20.65
-11.49% today · +8.4% 1Y
Tectonic Therapeutic, Inc. (NasdaqGM: TECX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $403.69M and employs 60 people.
Over the last twelve months the share price has gained 8.4%, trading between 15.52 and 39.53.
Tweenvest scores Tectonic Therapeutic, Inc. across four factors: quality 39/100, value 36/100. Its strongest factor is quality.
TECX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $403.69M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.56
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- $39.53
- 52-week low
- $15.52
- Avg volume (3M)
- —
- Shares outstanding
- 19.55M
- Employees
- 60
- Next earnings
- —
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
- ISIN
- US8789721086
- Listed since
- Jun 21, 2018
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| YD Bio LimitedNasdaqGM: YDES | $419.32M | $5.92 | -12.04% |
| Edding Genor Group Holdings LimitedSEHK: 6998 | $418.87M | HK$1.65 | -3.24% |
| Beijing Kawin Technology Share-Holding Co., Ltd.SHSE: 688687 | $412.63M | CN¥16.49 | -10.04% |
| DiaMedica Therapeutics Inc.NasdaqCM: DMAC | $408.22M | $7.57 | -9.12% |
| AVITA Medical, Inc.NasdaqCM: RCEL | $403.29M | $13.04 | -1.29% |
| ARS Pharmaceuticals, Inc.NasdaqGM: SPRY | $399.78M | $4.02 | -4.96% |
| Avalo Therapeutics, Inc.NasdaqCM: AVTX | $399.54M | $7.45 | -39.23% |
| Hubei Goto Biopharm Group Co., Ltd.SZSE: 300966 | $398.05M | CN¥23.32 | -5.78% |
Figures last refreshed Oct 18, 2026.